KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-07-08 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="TreatmentScheduledDAMYDA"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet TreatmentScheduledDAMYDA</b></p><a name="TreatmentScheduledDAMYDA"> </a><a name="hcTreatmentScheduledDAMYDA"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-ATC.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01AA01">L01AA01</a></td><td>Cyklophosphamid</td><td>L01AA01 - cyclophosphamide</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01AA03">L01AA03</a></td><td>Melfalan</td><td>L01AA03 - melphalan</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01AA09">L01AA09</a></td><td>Bendamustin</td><td>L01AA09 - bendamustine</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01DB01">L01DB01</a></td><td>Adriamycin (Doxorubicin)</td><td>L01DB01 - Doxorubicin</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-M05BA08">M05BA08</a></td><td>Zolendronat (Zoledronsyre)</td><td>M05BA08 - zoledronic acid</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-M05BA03">M05BA03</a></td><td>Pamidronat (Pamidronsyre)</td><td>M05BA03 - pamidronic acid</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-M05BX04">M05BX04</a></td><td>Denosumab</td><td>M05BX04 - denosumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FX08">L01FX08</a></td><td>Elotuzumab</td><td>L01FX08 - elotuzumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FC01">L01FC01</a></td><td>Daratumumab</td><td>L01FC01 - daratumumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FC02">L01FC02</a></td><td>Isatuximab</td><td>L01FC02 - isatuximab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XH03">L01XH03</a></td><td>Panobinostat</td><td>L01XH03 - panobinostat</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L04AX02">L04AX02</a></td><td>Thalidomid</td><td>L04AX02 - thalidomide</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L04AX04">L04AX04</a></td><td>Lenalidomid</td><td>L04AX04 - lenalidomide</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L04AX06">L04AX06</a></td><td>Pomalidomid</td><td>L04AX06 - pomalidomide</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XG01">L01XG01</a></td><td>Bortezomib</td><td>L01XG01 - bortezomib</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XG02">L01XG02</a></td><td>Carfilzomib</td><td>L01XG02 - carfilzomib</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01XG03">L01XG03</a></td><td>Ixazomib</td><td>L01XG03 - ixazomib</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-H02">H02</a></td><td>Steroid (kun steroid, givet som palliation)</td><td>H02 - CORTICOSTEROIDS FOR SYSTEMIC USE</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-SKS.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/SKS</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-SKS.html#SKS-BWG">BWG</a></td><td>Strålebehandling</td><td>BWG - Strålebehandling</td></tr><tr><td><a href="CodeSystem-SKS.html#SKS-BWHA309">BWHA309</a></td><td>Højdosis melfalan med stamcellestøtte</td><td>BWHA309 - Behandling med højdosis melfalan (konditionering)</td></tr><tr><td><a href="CodeSystem-SKS.html#SKS-BOQF1">BOQF1</a></td><td>Allogen KMT</td><td>BOQF1 - Allogen knoglemarvstransplantation</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-GenericValues.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-GenericValues.html#GenericValues-other">other</a></td><td>Øvrig</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li></ul></div>
</text>
<url value="https://kip.rkkp.dk/fhir/ValueSet/TreatmentScheduledDAMYDA"/>
<version value="2.12.0"/>
<name value="TreatmentScheduledDAMYDA"/>
<title value="Planlagt behandling (DAMYDA)"/>
<status value="active"/>
<experimental value="true"/>
<date value="2022-07-08T00:00:00+02:00"/>
<publisher
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<contact>
<name
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<telecom>
<system value="url"/>
<value value="https://trifork.com"/>
</telecom>
<telecom>
<system value="email"/>
<value value="rbk@trifork.com"/>
</telecom>
</contact>
<description value="Planlagt behandling (DAMYDA)"/>
<compose>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/ATC"/>
<concept>
<code value="L01AA01"/>
<display value="Cyklophosphamid"/>
</concept>
<concept>
<code value="L01AA03"/>
<display value="Melfalan"/>
</concept>
<concept>
<code value="L01AA09"/>
<display value="Bendamustin"/>
</concept>
<concept>
<code value="L01DB01"/>
<display value="Adriamycin (Doxorubicin)"/>
</concept>
<concept>
<code value="M05BA08"/>
<display value="Zolendronat (Zoledronsyre)"/>
</concept>
<concept>
<code value="M05BA03"/>
<display value="Pamidronat (Pamidronsyre)"/>
</concept>
<concept>
<code value="M05BX04"/>
<display value="Denosumab"/>
</concept>
<concept>
<code value="L01FX08"/>
<display value="Elotuzumab"/>
</concept>
<concept>
<code value="L01FC01"/>
<display value="Daratumumab"/>
</concept>
<concept>
<code value="L01FC02"/>
<display value="Isatuximab"/>
</concept>
<concept>
<code value="L01XH03"/>
<display value="Panobinostat"/>
</concept>
<concept>
<code value="L04AX02"/>
<display value="Thalidomid"/>
</concept>
<concept>
<code value="L04AX04"/>
<display value="Lenalidomid"/>
</concept>
<concept>
<code value="L04AX06"/>
<display value="Pomalidomid"/>
</concept>
<concept>
<code value="L01XG01"/>
<display value="Bortezomib"/>
</concept>
<concept>
<code value="L01XG02"/>
<display value="Carfilzomib"/>
</concept>
<concept>
<code value="L01XG03"/>
<display value="Ixazomib"/>
</concept>
<concept>
<code value="H02"/>
<display value="Steroid (kun steroid, givet som palliation)"/>
</concept>
</include>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/SKS"/>
<concept>
<code value="BWG"/>
<display value="Strålebehandling"/>
</concept>
<concept>
<code value="BWHA309"/>
<display value="Højdosis melfalan med stamcellestøtte"/>
</concept>
<concept>
<code value="BOQF1"/>
<display value="Allogen KMT"/>
</concept>
</include>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"/>
<concept>
<code value="other"/>
<display value="Øvrig"/>
</concept>
</include>
</compose>
</ValueSet>